Sonia Garg, MD
Cardiovascular Disease (Cardiology) · Berkeley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 10
Offices
10 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp · California Pacific Medical Center- Van Ness Campus · Eden Medical Center · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Garg’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
State licence records
1 licence
- Texas Q9157Physician License · since 2016 · expires 2025-08-31Canc Non-RenewalNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- Eden Medical CenterCastro Valley, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.122, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Eden Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.122 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.89) · 819 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.46 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 137.41 (92.94 to 181.88) · 70 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 78 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.1 · 207 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 355 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 1,714 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,697 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.1 to 0.5) · 4,676 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.69 (0.53 to 4.85) · 860 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0 to 3.24) · 251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.75 (1.17 to 4.32) · 818 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.76 (0 to 15.78) · 261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.09 (2.08 to 10.1) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.64 (0.16 to 3.12) · 233 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,132 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 60 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.431 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.292 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.307 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.61 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 258 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 22.6 · 225 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 2.4 · 367 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 390 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 58 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 88 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.6 to 17.4) · 68 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 205 cases | No different | Jan 2024 – Dec 2024 |
What patients said (431 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$88,248
Medicare paid this office $88,248 for 264 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 68 | $20,853 | $99 |
| Critical care, first 30-74 minutes | 25 | $16,571 | $184 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 39 | $7,748 | $199 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $7,340 | $66 |
| Return visit (30+ min) | 54 | $6,784 | $100 |
See all 14 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 68 | $20,853 | $99 |
| Critical care, first 30-74 minutes | 25 | $16,571 | $184 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 39 | $7,748 | $199 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $7,340 | $66 |
| Return visit (30+ min) | 54 | $6,784 | $100 |
| New patient visit (45+ min) | 34 | $5,350 | $157 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $4,809 | $150 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $3,186 | $114 |
| Short return visit (20+ min) | 26 | $2,142 | $71 |
| Long return visit (40+ min) | 11 | $1,411 | $128 |
| Insertion of tube in right heart chambers for measurement | 12 | $1,210 | $101 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 15 | $914 | $61 |
| Heart muscle strain imaging | 15 | $578 | $39 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 40 | $556 | $14 |
Who their Medicare patients are
264 Original Medicare patients in 2024. Average age 74 · Under 65 14% · 85 and older 18% · Women 41% · Also on Medicaid 33% · Health risk score 2.78. Sicker patients than 9 in 10 peers; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Heart failure 72% · Chronic kidney disease 57% · Coronary heart disease 56% · Diabetes 48% · Atrial fibrillation 48% · COPD 28% · Depression 27% · Stroke 22% · Cancer 16% · Dementia 14%.
The office billed $382,020, Medicare allowed $112,394 and paid $88,248; for 859 services of 41 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 264 | 859 | 74 | 2.78 | $382,020 | $88,248 |
| 2023 | 212 | 490 | 65 | 3.06 | $142,798 | $32,051 |
| 2022 | 705 | 1,787 | 69 | 2.98 | $386,696 | $73,233 |
| 2021 | 238 | 657 | 64 | 3.42 | $200,505 | $45,160 |
| 2020 | 323 | 783 | 67 | 3.67 | $209,644 | $45,920 |
| 2019 | 294 | 777 | 67 | 3.28 | $309,412 | $62,979 |
| 2018 | 312 | 731 | 68 | 3.02 | $309,191 | $62,786 |
| 2017 | 253 | 758 | 66 | 3.17 | $249,514 | $62,640 |
| 2016 | 65 | 195 | 61 | 3.94 | $58,480 | $15,465 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $10,653 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $4,331 | $60 |
| Return visit (30+ min) | 43 | $3,572 | $71 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,292 | $127 |
| Long return visit (40+ min) | 19 | $2,165 | $108 |
| Short return visit (20+ min) | 20 | $986 | $41 |
| Hospital discharge day management, 30 minutes or less | 16 | $966 | $60 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 75 | $519 | $6 |
2022: 14 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 66 | $20,299 | $81 |
| Return visit (30+ min) | 62 | $5,928 | $75 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 46 | $5,512 | $57 |
| Critical care, first 30-74 minutes | 11 | $5,301 | $183 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,178 | $157 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 457 | $4,300 | $6 |
| Long return visit (40+ min) | 21 | $2,676 | $111 |
| Hospital discharge day management, more than 30 minutes | 17 | $1,523 | $85 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,390 | $107 |
| Hospital discharge day management, 30 minutes or less | 20 | $1,220 | $58 |
| Evaluation of lower heart chamber assist device | 13 | $909 | $30 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 73 | $784 | $11 |
| Short return visit (20+ min) | 13 | $747 | $47 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 22 | $119 | $5 |
2021: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $13,021 | $80 |
| Return visit (30+ min) | 63 | $6,809 | $78 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $4,475 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,078 | $157 |
| Biopsy of heart muscle | 14 | $2,756 | $172 |
| Long return visit (40+ min) | 16 | $2,131 | $118 |
| Short return visit (20+ min) | 24 | $1,481 | $46 |
| Hospital discharge day management, 30 minutes or less | 21 | $1,334 | $58 |
| Hospital discharge day management, more than 30 minutes | 15 | $1,303 | $87 |
| Return visit (30+ min) | 12 | $870 | $67 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 70 | $552 | $7 |
| Evaluation of lower heart chamber assist device | 14 | $480 | $30 |
2020: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 62 | $14,244 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 53 | $5,906 | $54 |
| Return visit (30+ min) | 72 | $5,536 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,468 | $161 |
| Hospital discharge day management, 30 minutes or less | 27 | $1,525 | $56 |
| Hospital discharge day management, more than 30 minutes | 15 | $1,498 | $88 |
| Short return visit (20+ min) | 23 | $1,178 | $41 |
| Long return visit (40+ min) | 13 | $1,155 | $89 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 108 | $1,036 | $7 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $498 | $41 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 28 | $350 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 11 | $76 | $7 |
2019: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 55 | $15,992 | $82 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 92 | $13,270 | $144 |
| Return visit (30+ min) | 93 | $9,101 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 47 | $7,883 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,351 | $161 |
| Long return visit (40+ min) | 27 | $2,531 | $84 |
| Hospital discharge day management, more than 30 minutes | 16 | $1,369 | $86 |
| Hospital discharge day management, 30 minutes or less | 20 | $1,166 | $58 |
| Evaluation of lower heart chamber assist device | 12 | $781 | $37 |
2018: 11 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 104 | $16,362 | $157 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 42 | $13,724 | $82 |
| Return visit (30+ min) | 67 | $6,104 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 43 | $5,523 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,450 | $159 |
| Long return visit (40+ min) | 43 | $4,076 | $83 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,183 | $109 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 35 | $2,068 | $59 |
| Hospital discharge day management, 30 minutes or less | 22 | $1,288 | $59 |
| Hospital discharge day management, more than 30 minutes | 15 | $1,246 | $83 |
| Evaluation of lower heart chamber assist device | 17 | $816 | $34 |
2017: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 60 | $15,323 | $82 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 48 | $8,798 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 57 | $8,328 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $6,446 | $161 |
| Long return visit (40+ min) | 48 | $4,711 | $84 |
| Return visit (30+ min) | 57 | $4,641 | $59 |
| Biopsy of heart muscle | 20 | $3,692 | $161 |
| Hospital discharge day management, 30 minutes or less | 28 | $1,805 | $56 |
| Evaluation of lower heart chamber assist device | 12 | $1,334 | $37 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,117 | $86 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 20 | $1,026 | $51 |
2016: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $3,751 | $57 |
| Biopsy of heart muscle | 12 | $2,417 | $186 |
| Return visit (30+ min) | 20 | $1,246 | $62 |
| Hospital discharge day management, 30 minutes or less | 12 | $722 | $56 |
Medicaid work
$1,541 in 2023
Medicaid paid $1,541 for 212 billed services this clinician did in 2023, up to 129 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 212 | $1,541 |
| 2023 | 212 | 1 | 129 | $1,541 |
| 2022 | 751 | 1 | 322 | $4,728 |
| 2021 | 179 | 1 | 104 | $987 |
| 2020 | 41 | 1 | 29 | $142 |
See the largest Medicaid services in earlier years
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 751 | $4,728 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 179 | $987 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 41 | $142 |
Drugs they prescribed that Part D paid
$352,834
Pharmacies billed $352,834 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
951 generic and 161 brand-name prescriptions · $352,834 in drug cost · 18 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Entresto | 42 | $50,268 | $1,197 |
| Sirolimus | 42 | $36,152 | $861 |
| Jardiance | 41 | $32,946 | $804 |
| Eliquis | 41 | $31,145 | $760 |
| Valganciclovir | 23 | $2,089 | $91 |
See all 31 drugs
| Entresto | 42 | $50,268 | $1,197 |
| Sirolimus | 42 | $36,152 | $861 |
| Jardiance | 41 | $32,946 | $804 |
| Eliquis | 41 | $31,145 | $760 |
| Valganciclovir | 23 | $2,089 | $91 |
| Eplerenone | 27 | $1,673 | $62 |
| Cyclosporine Modified | 11 | $1,229 | $112 |
| Metoprolol | 55 | $775 | $14 |
| Tacrolimus | 16 | $761 | $48 |
| Atorvastatin | 62 | $683 | $11 |
| Isosorbide Dinitrate | 12 | $672 | $56 |
| Losartan | 70 | $651 | $9 |
| Bumetanide | 13 | $447 | $34 |
| Carvedilol | 60 | $438 | $7 |
| Rosuvastatin | 34 | $347 | $10 |
| Pantoprazole | 31 | $322 | $10 |
| Nifedipine Er | 14 | $310 | $22 |
| Torsemide | 15 | $303 | $20 |
| Hydralazine | 25 | $270 | $11 |
| Ezetimibe | 19 | $261 | $14 |
| Spironolactone | 36 | $251 | $7 |
| Gabapentin | 20 | $241 | $12 |
| Prednisone | 26 | $160 | $6 |
| Amlodipine Besylate | 36 | $156 | $4 |
| Furosemide | 44 | $136 | $3 |
| Pravastatin | 18 | $114 | $6 |
| Warfarin | 21 | $99 | $5 |
| Clopidogrel | 17 | $98 | $6 |
| Lisinopril | 23 | $82 | $4 |
| Sulfamethoxazole-Trimethoprim | 11 | $68 | $6 |
| Omeprazole | 12 | $18 | $1 |
Year by year
| 2024 | 1,112 | 223 | None | 14% | $352,834 |
| 2023 | 905 | 181 | None | None | $198,124 |
| 2022 | 757 | 165 | None | None | $185,214 |
| 2021 | 854 | 188 | None | 20% | $376,782 |
| 2020 | 754 | 168 | None | None | $92,943 |
| 2019 | 553 | 129 | None | None | $61,494 |
| 2018 | 643 | 116 | None | None | $59,313 |
| 2017 | 433 | 95 | None | None | $43,431 |
| 2016 | 60 | 22 | None | None | $4,134 |
| 2015 | 21 | None | 0% (0) | None | $327 |
| 2013 | 18 | None | 0% (0) | 0% | $271 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 25 drugs
| Entresto | 61 | $80,937 | $1,327 |
| Eliquis | 29 | $23,822 | $821 |
| Jardiance | 26 | $22,629 | $870 |
| Cyclosporine Modified | 11 | $2,284 | $208 |
| Torsemide | 39 | $1,541 | $40 |
| Rosuvastatin | 23 | $1,213 | $53 |
| Metoprolol | 47 | $1,174 | $25 |
| Eplerenone | 12 | $1,107 | $92 |
| Atorvastatin | 32 | $921 | $29 |
| Potassium Chloride | 12 | $495 | $41 |
| Gabapentin | 20 | $475 | $24 |
| Spironolactone | 37 | $472 | $13 |
| Carvedilol | 44 | $467 | $11 |
| Pantoprazole | 26 | $461 | $18 |
| Warfarin | 32 | $423 | $13 |
| Losartan | 33 | $400 | $12 |
| Digoxin | 15 | $386 | $26 |
| Hydralazine | 11 | $223 | $20 |
| Pravastatin | 25 | $195 | $8 |
| Furosemide | 20 | $137 | $7 |
| Prednisone | 19 | $137 | $7 |
| Allopurinol | 11 | $125 | $11 |
| Amlodipine Besylate | 25 | $113 | $5 |
| Lisinopril | 17 | $90 | $5 |
| Trazodone | 17 | $87 | $5 |
2022: 24 drugs
| Entresto | 69 | $82,808 | $1,200 |
| Eliquis | 19 | $19,727 | $1,038 |
| Farxiga | 19 | $19,639 | $1,034 |
| Jardiance | 22 | $18,213 | $828 |
| Mycophenolic Acid | 11 | $9,109 | $828 |
| Tacrolimus | 25 | $5,628 | $225 |
| Potassium Chloride | 15 | $2,180 | $145 |
| Torsemide | 30 | $1,762 | $59 |
| Eplerenone | 12 | $1,607 | $134 |
| Metoprolol | 47 | $1,075 | $23 |
| Warfarin | 40 | $680 | $17 |
| Allopurinol | 23 | $475 | $21 |
| Spironolactone | 42 | $448 | $11 |
| Carvedilol | 38 | $400 | $11 |
| Atorvastatin | 16 | $320 | $20 |
| Diltiazem 24hr Er (Cd) | 11 | $309 | $28 |
| Rosuvastatin | 11 | $256 | $23 |
| Pantoprazole | 15 | $211 | $14 |
| Lisinopril | 24 | $136 | $6 |
| Pravastatin | 15 | $129 | $9 |
| Losartan | 17 | $123 | $7 |
| Furosemide | 14 | $87 | $6 |
| Amlodipine Besylate | 13 | $77 | $6 |
| Sulfamethoxazole-Trimethoprim | 19 | $62 | $3 |
2021: 25 drugs
| Entresto | 81 | $77,109 | $952 |
| Eliquis | 17 | $15,228 | $896 |
| Farxiga | 13 | $7,981 | $614 |
| Valganciclovir | 18 | $7,545 | $419 |
| Tacrolimus | 20 | $5,294 | $265 |
| Eplerenone | 16 | $2,315 | $145 |
| Potassium Chloride | 26 | $2,059 | $79 |
| Torsemide | 36 | $1,896 | $53 |
| Warfarin | 53 | $1,438 | $27 |
| Metoprolol | 41 | $1,332 | $32 |
| Ezetimibe | 12 | $900 | $75 |
| Pantoprazole | 33 | $788 | $24 |
| Carvedilol | 28 | $467 | $17 |
| Atorvastatin | 23 | $343 | $15 |
| Spironolactone | 37 | $334 | $9 |
| Hydralazine | 13 | $272 | $21 |
| Lisinopril | 35 | $271 | $8 |
| Digoxin | 12 | $259 | $22 |
| Prednisone | 20 | $247 | $12 |
| Amlodipine Besylate | 33 | $201 | $6 |
| Furosemide | 20 | $197 | $10 |
| Pravastatin | 14 | $181 | $13 |
| Sulfamethoxazole-Trimethoprim | 32 | $143 | $4 |
| Tamsulosin | 14 | $142 | $10 |
| Losartan | 14 | $123 | $9 |
2020: 20 drugs
| Entresto | 36 | $25,162 | $699 |
| Valganciclovir | 13 | $6,904 | $531 |
| Torsemide | 38 | $1,325 | $35 |
| Warfarin | 42 | $1,017 | $24 |
| Metoprolol | 50 | $815 | $16 |
| Hydralazine | 23 | $714 | $31 |
| Potassium Chloride | 15 | $523 | $35 |
| Atorvastatin | 42 | $446 | $11 |
| Pravastatin | 32 | $426 | $13 |
| Carvedilol | 24 | $255 | $11 |
| Pantoprazole | 22 | $242 | $11 |
| Prednisone | 25 | $234 | $9 |
| Ezetimibe | 14 | $171 | $12 |
| Furosemide | 27 | $141 | $5 |
| Sulfamethoxazole-Trimethoprim | 12 | $136 | $11 |
| Lisinopril | 20 | $112 | $6 |
| Gabapentin | 16 | $110 | $7 |
| Amlodipine Besylate | 20 | $107 | $5 |
| Spironolactone | 17 | $104 | $6 |
| Tamsulosin | 14 | $95 | $7 |
2019: 12 drugs
| Entresto | 25 | $15,267 | $611 |
| Torsemide | 32 | $672 | $21 |
| Carvedilol | 62 | $570 | $9 |
| Atorvastatin | 41 | $504 | $12 |
| Pravastatin | 28 | $453 | $16 |
| Metoprolol | 16 | $213 | $13 |
| Sulfamethoxazole-Trimethoprim | 15 | $201 | $13 |
| Hydralazine | 12 | $187 | $16 |
| Prednisone | 18 | $171 | $9 |
| Furosemide | 29 | $151 | $5 |
| Lisinopril | 18 | $119 | $7 |
| Pantoprazole | 13 | $119 | $9 |
2018: 19 drugs
| Valganciclovir | 13 | $26,013 | $2,001 |
| Entresto | 20 | $9,198 | $460 |
| Tacrolimus | 11 | $1,396 | $127 |
| Hydralazine | 18 | $700 | $39 |
| Torsemide | 26 | $621 | $24 |
| Potassium Chloride | 20 | $612 | $31 |
| Pravastatin | 28 | $519 | $19 |
| Atorvastatin | 25 | $441 | $18 |
| Carvedilol | 44 | $331 | $8 |
| Tamsulosin | 14 | $287 | $21 |
| Levothyroxine | 20 | $273 | $14 |
| Furosemide | 45 | $230 | $5 |
| Spironolactone | 34 | $204 | $6 |
| Pantoprazole | 20 | $189 | $9 |
| Sulfamethoxazole-Trimethoprim | 16 | $160 | $10 |
| Gabapentin | 16 | $134 | $8 |
| Warfarin | 13 | $130 | $10 |
| Lisinopril | 21 | $128 | $6 |
| Prednisone | 11 | $75 | $7 |
2017: 12 drugs
| Potassium Chloride | 23 | $1,118 | $49 |
| Torsemide | 21 | $643 | $31 |
| Carvedilol | 47 | $380 | $8 |
| Azathioprine | 12 | $323 | $27 |
| Atorvastatin | 14 | $237 | $17 |
| Pravastatin | 15 | $197 | $13 |
| Valacyclovir | 12 | $191 | $16 |
| Gabapentin | 11 | $122 | $11 |
| Warfarin | 15 | $117 | $8 |
| Lisinopril | 33 | $112 | $3 |
| Spironolactone | 13 | $74 | $6 |
| Losartan | 13 | $56 | $4 |
Money from drug and device companies
$884 in 2025
| 2025 | 8 | 18 | None | $884 |
| 2024 | 3 | 3 | None | $157 |
| 2023 | 1 | 1 | None | $202 |
| 2022 | 1 | 1 | None | $15 |
| 2019 | 3 | 6 | None | $85 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abiomed | None | $472 | 6 payments
|
| United Therapeutics | None | $107 | 2 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $100 | 4 payments
|
| Boston Scientific | Lux-Dx Insertable Cardiac Monitor | $82 | 1 payment
|
| Actelion Pharmaceuticals US | Opsynvi | $58 | 2 payments
|
| Scpharmaceuticals | Furoscix | $26 | 1 payment
|
See all 18 published payments
| Abbott Laboratories | Meals · 2025-11-09 | Thoratec Heartmate 3 Lvas Implant Kit | $21 |
| Boston Scientific | Meals · 2025-09-25 | Lux-Dx Insertable Cardiac Monitor | $82 |
| Actelion Pharmaceuticals US | Meals · 2025-08-28 | Opsynvi | $29 |
| United Therapeutics | Meals · 2025-08-21 | None | $64 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-08-13 | Kerendia | $31 |
| United Therapeutics | Meals · 2025-07-11 | None | $43 |
| Scpharmaceuticals | Meals · 2025-06-12 | Furoscix | $26 |
| Abiomed | Meals · 2025-06-03 | None | $40 |
| Abiomed | Meals · 2025-06-03 | None | $150 |
| Abiomed | Travel · 2025-06-03 | None | $233 |
| Abiomed | Meals · 2025-06-03 | None | $4 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-27 | Kerendia | $25 |
| Actelion Pharmaceuticals US | Meals · 2025-05-14 | Uptravi | $29 |
| Abiomed | Meals · 2025-04-25 | None | $25 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-15 | Camzyos | $19 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-02-27 | Kerendia | $24 |
| Bayer Healthcare Pharmaceuticals | Education · 2025-02-27 | Kerendia | $20 |
| Abiomed | Meals · 2025-02-05 | None | $20 |
See earlier years (2024, 2023, 2022, 2019)
2024: $157
| Impulse Dynamics (USA) | Optimizer | $129 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $15 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $13 | 1 payment
|
2023: $202
| Abbott Laboratories | Thoratec Heartmate 3 Lvas Implant Kit | $202 | 1 payment
|
2022: $15
| Merck Sharp & Dohme | Gardasil 9 | $15 | 1 payment
|
2019: $85
| Pfizer | Prevnar - 13 | $43 | 3 payments
|
| GlaxoSmithKline | Bexsero | $27 | 2 payments
|
| Merck Sharp & Dohme | Rotateq | $15 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 74.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1386873370
- Licence
- TX Q9157Texas Q9157: Canc Non-Renewal
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RA0001X (207RA0001X); Cardiology (207RC0000X); General practice (208D00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2009-07-10
- NPI last updated
- 2026-05-21
- NPI record certified
- 2026-05-21
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 5323 Harry Hines Blvd, Dallas, TX, 75390 · 5939 Harry Hines Blvd, Dallas, TX, 75390 · 6201 Harry Hines Blvd, Dallas, TX, 75390